| Primary |
| Product Used For Unknown Indication |
36.3% |
| Pneumonia |
11.7% |
| Infection |
5.1% |
| Hypertension |
4.8% |
| Anaesthesia |
4.4% |
| Wound Infection |
3.7% |
| Lower Respiratory Tract Infection |
3.3% |
| Pleurisy |
2.9% |
| Cellulitis |
2.6% |
| Depression |
2.6% |
| Nausea |
2.6% |
| Pain |
2.6% |
| Urinary Tract Infection |
2.6% |
| Atrial Fibrillation |
2.2% |
| Insomnia |
2.2% |
| Meningitis Staphylococcal |
2.2% |
| Pharyngitis |
2.2% |
| Renal Transplant |
2.2% |
| Septic Embolus |
2.2% |
| Endocarditis |
1.8% |
|
| Anaphylactic Reaction |
13.0% |
| Tachycardia |
10.4% |
| Jaundice |
6.5% |
| Hypersensitivity |
5.2% |
| Rash Macular |
5.2% |
| Suicidal Ideation |
5.2% |
| Tremor |
5.2% |
| Blood Albumin Increased |
3.9% |
| Cholecystitis |
3.9% |
| Enterocolitis Haemorrhagic |
3.9% |
| International Normalised Ratio Increased |
3.9% |
| Jaundice Cholestatic |
3.9% |
| Liver Function Test Abnormal |
3.9% |
| Myocardial Infarction |
3.9% |
| Pulmonary Embolism |
3.9% |
| Renal Impairment |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Therapeutic Response Decreased |
3.9% |
| Wheezing |
3.9% |
| Accidental Overdose |
2.6% |
|
| Secondary |
| Pneumonia |
19.2% |
| Hypertension |
13.8% |
| Bacteraemia |
10.0% |
| Immunosuppression |
5.0% |
| Drug Use For Unknown Indication |
4.2% |
| Pneumonia Aspiration |
4.2% |
| Wound Infection |
4.2% |
| Depression |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Urinary Tract Infection |
3.8% |
| Cardiac Failure |
3.3% |
| Endocarditis |
3.3% |
| Pyothorax |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Aortic Dissection |
2.9% |
| Convulsion |
2.5% |
| Lower Respiratory Tract Infection |
2.5% |
| Pharyngitis |
2.5% |
| Renal Transplant |
2.5% |
| Cholecystitis Acute |
2.1% |
|
| Toxic Epidermal Necrolysis |
12.8% |
| Hypersensitivity |
8.5% |
| Pulmonary Embolism |
6.4% |
| Renal Impairment |
6.4% |
| Acute Generalised Exanthematous Pustulosis |
4.3% |
| Alveolitis Allergic |
4.3% |
| Anaphylactic Reaction |
4.3% |
| Drug Interaction |
4.3% |
| Drug Level Decreased |
4.3% |
| Duodenal Ulcer Haemorrhage |
4.3% |
| Hepatic Function Abnormal |
4.3% |
| Hepatocellular Injury |
4.3% |
| Liver Function Test Abnormal |
4.3% |
| Medication Error |
4.3% |
| Photosensitivity Reaction |
4.3% |
| Renal Disorder |
4.3% |
| Restlessness |
4.3% |
| Thrombocytopenia |
4.3% |
| Tongue Discolouration |
4.3% |
| Abnormal Behaviour |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Drug Use For Unknown Indication |
12.1% |
| Pneumonia |
7.7% |
| Prophylaxis |
7.4% |
| Hypertension |
5.1% |
| Anxiety |
3.8% |
| Oedema |
3.3% |
| Abdominal Pain |
3.2% |
| Decreased Appetite |
3.2% |
| Epilepsy |
2.7% |
| Ill-defined Disorder |
2.5% |
| Nausea |
2.4% |
| Pain |
2.3% |
| Acute Sinusitis |
1.9% |
| Hepatitis |
1.9% |
| Pruritus |
1.9% |
| Adult T-cell Lymphoma/leukaemia |
1.7% |
| Hyperlipidaemia |
1.6% |
| Infection Prophylaxis |
1.6% |
| Prostate Cancer |
1.5% |
|
| Premature Labour |
14.4% |
| Pneumonia |
9.6% |
| Vomiting |
8.7% |
| Transfusion |
5.8% |
| Ventricular Septal Defect |
5.8% |
| Liver Function Test Abnormal |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Diarrhoea |
3.8% |
| Erysipelas |
3.8% |
| Heparin-induced Thrombocytopenia |
3.8% |
| Multi-organ Failure |
3.8% |
| Myopathy |
3.8% |
| Pneumonia Cytomegaloviral |
3.8% |
| Sepsis |
3.8% |
| Subdural Haemorrhage |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| Antibiotic Level Below Therapeutic |
2.9% |
| Cerebral Infarction |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Idiopathic Thrombocytopenic Purpura |
2.9% |
|
| Interacting |
| Helicobacter Infection |
33.3% |
| Hypertension |
22.2% |
| Ischaemic Heart Disease Prophylaxis |
22.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Urinary Tract Infection |
11.1% |
|
|
